Search results
US FDA grants accelerated approval to Genfit and Ipsen's liver disease drug
AOL· 3 days ago(Reuters) -The U.S. Food and Drug Administration granted accelerated approval to French drugmakers Ipsen and Genfit's drug for a chronic inflammatory liver disease, Iqirvo, the companies said ...
Brii Bio Presents New Data from Its Ongoing Phase 2 Chronic Hepatitis B Trials at EASL™ Congress...
The Tomahawk· 7 days agoNew translational data demonstrate that BRII-179-induced immune responses are associated with high HBsAg reduction in a subset of participants with chronic HBV infection
Ipsen gets hot on cold tumors, inking $1.2B biobucks deal for Marengo's T-cell engagers
FierceBiotech· 7 days agoIpsen is hot on Marengo Therapeutics’ ability to treat “cold” tumors. The French drugmaker has...
Will AI Become Friend or Foe to Animators?
Variety· 5 days agoAs the animation community deals with industry contraction, one force inspires more fear and uncertainty than any other: Artificial intelligence. The Annecy Festival will screen four works using ...